文献速递心脑血管急症复苏、休克与脓毒症

供氧对急性ST段抬高型心肌梗死死亡率的影响:系统评价与Meta分析

Effect of oxygen supply on mortality in acute ST-elevation myocardial infarction: systematic review and meta-analysis.
PubMed 文献 · Eur J Emerg Med · 2021-01-01
一句话结论在STEMI患者中,高流量供氧(≥6 L/min)可能降低短期死亡率(RR 0.83),但GRADE证据质量极低,尚不能得出确定性结论。

该系统评价与Meta分析纳入5项RCT共7703例STEMI患者,比较系统使用高流量氧(≥6 L/min)与室内空气或低流量氧的临床效果。高流量供氧与短期死亡率显著降低相关(RR 0.83;95%CI 0.70-0.98;I²=0%),最长随访死亡率亦降低(RR 0.83;95%CI 0.71-0.97),但心力衰竭无显著风险降低(RR 0.84;95%CI 0.60-1.18),复发性心肌梗死结果矛盾且未达统计学显著(RR 1.47;95%CI 0.84-2.56),GRADE证据质量为极低。作者认为高流量供氧可能降低STEMI患者短期死亡率,但汇总数据不足以得出确定性结论。

要点

  • 在STEMI患者中,系统使用高流量氧(≥6 L/min)与短期死亡率降低相关(RR 0.83;95%CI 0.70-0.98;I²=0%)。
  • 最长随访死亡率同样降低(RR 0.83;95%CI 0.71-0.97;I²=0%),但GRADE证据质量评为极低。
  • 心力衰竭无显著风险降低(RR 0.84;95%CI 0.60-1.18;I²=0%)。
  • 复发性心肌梗死结果矛盾且未达统计学显著(RR 1.47;95%CI 0.84-2.56;I²=0%)。
  • 作者认为高流量供氧可能降低STEMI短期死亡率,但汇总数据不足以得出确定性结论。

适用人群与场景

  • STEMI患者,纳入随机对照试验中系统使用高流量氧(≥6 L/min)与室内空气或低流量氧比较的人群。

研究设计与关键结果

  • 研究类型为系统评价与Meta分析,纳入5项RCT共7703例STEMI患者。
  • 高流量供氧(≥6 L/min)与短期死亡率显著风险降低相关(RR 0.83;95%CI 0.70-0.98;I²=0%)。
  • 最长随访死亡率降低(RR 0.83;95%CI 0.71-0.97;I²=0%),但心力衰竭无显著风险降低(RR 0.84;95%CI 0.60-1.18;I²=0%)。
  • 复发性心肌梗死结果矛盾,倾向于低氧方案(RR 1.47;95%CI 0.84-2.56;I²=0%),未达统计学显著。
  • GRADE证据质量评为极低。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入5项RCT,使用GRADE方法评估证据质量,Cochrane偏倚风险工具评估偏倚风险。
  • GRADE证据质量:极低。
  • 局限:作者指出汇总数据不够稳健,不足以得出确定性结论。

对床旁实践的改变

  • 作者认为高流量供氧可能降低STEMI患者短期死亡率,但汇总数据不足以得出确定性结论。
  • GRADE证据质量极低,该结果可能影响对STEMI患者常规高流量供氧的决策,但原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Previous studies stated that high oxygen supply in patients with myocardial infarction (MI) was not associated with improved outcomes. However, the particularities of ST-elevation myocardial infarction (STEMI) and the results of a recent trial raised the question if this subgroup of patients benefits from high oxygen supply. This study aims to evaluate the clinical effect of high oxygen supply in patients with STEMI using a systematic review of the available literature. All randomized controlled trials (RCTs) evaluating the systematic use of high oxygen (6 L/min or higher) versus room air or lower oxygen supply in STEMI patients were included. Systematic review with meta-analysis of trials retrieved in July 2020. Six databases were searched. The confidence in the pooled estimates was ascertained through the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. Risk of bias was evaluated using the Cochrane risk of bias tool. There were five eligible RCTs (7703 patients). High oxygen supply was associated with a significant risk reduction of short-term mortality [risk ratio (RR) 0.83; 95% confidence interval (CI), 0.70-0.98; I2 = 0%]. Mortality (longest follow-up) (RR 0.83; 95% CI, 0.71-0.97; I2 = 0%) and heart failure (RR 0.84; 95% CI, 0.60-1.18; I2 = 0%) did not present a risk reduction. Recurrent MI presented a contradictory result, favouring the lower oxygen protocol (RR 1.47; 95% CI, 0.84-2.56; I2 = 0%). The GRADE analysis was very low. High oxygen supply may be associated with a decrease in short-term mortality in STEMI patients, but the pooled data are not robust enough to allow definitive conclusions.

来源:Eur J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Alves M, Prada L, Costa J, et al. Effect of oxygen supply on mortality in acute ST-elevation myocardial infarction: systematic review and meta-analysis. Eur J Emerg Med. 2021. PMID: 33079738. doi:10.1097/MEJ.0000000000000764

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。